Sameem M Abedin

8PUBLICATIONS
51CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 03, 2026
Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Lyndsey Runaas, Salena Fank, Katie Palen

|Apr 30, 2025
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.

Sameem Abedin, Michael J Martens, Javier Bolaños-Meade

|Mar 19, 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.

Zachariah DeFilipp, Haesook T Kim, Laura W Knight

|Feb 15, 2025
Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia.

Sameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani

|Jan 24, 2025
The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based frontline treatment.

Sameem Abedin, Geoffrey L Uy, Laura C Michaelis

|Dec 20, 2024
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies.

Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero

Pageof 2

Frequent Collaborators

5 joint publications

Mehdi Hamadani

2 joint publications

Nirav N Shah

2 joint publications

Monzr M Al Malki

1 joint publications

Mohamed A Kharfan-Dabaja